Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17889527rdf:typepubmed:Citationlld:pubmed
pubmed-article:17889527lifeskim:mentionsumls-concept:C0000968lld:lifeskim
pubmed-article:17889527lifeskim:mentionsumls-concept:C2746042lld:lifeskim
pubmed-article:17889527pubmed:issue22lld:pubmed
pubmed-article:17889527pubmed:dateCreated2007-10-16lld:pubmed
pubmed-article:17889527pubmed:abstractText2-(2-Chloro-6-fluorophenyl)acetamides having 2,2-difluoro-2-aryl/heteroaryl-ethylamine P3 and oxyguanidine P1 substituents are potent thrombin inhibitors (K(i)=0.9-33.9 nM). 2-(5-Chloro-pyridin-2-yl)-2,2-difluoroethylamine was the best P3 substituent, yielding the most potent inhibitor (K(i)=0.7 nM). Replacing the P3 heteroaryl group with a phenyl ring or replacing the difluoro substitution with dimethyl or cyclopropyl groups in the linker reduced the affinity for thrombin significantly. The aminopyridine P1s also provided an increase in potency.lld:pubmed
pubmed-article:17889527pubmed:languageenglld:pubmed
pubmed-article:17889527pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17889527pubmed:citationSubsetIMlld:pubmed
pubmed-article:17889527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17889527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17889527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17889527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17889527pubmed:statusMEDLINElld:pubmed
pubmed-article:17889527pubmed:monthNovlld:pubmed
pubmed-article:17889527pubmed:issn0960-894Xlld:pubmed
pubmed-article:17889527pubmed:authorpubmed-author:PlayerMark...lld:pubmed
pubmed-article:17889527pubmed:authorpubmed-author:TomczukBruceBlld:pubmed
pubmed-article:17889527pubmed:authorpubmed-author:LuTianbaoTlld:pubmed
pubmed-article:17889527pubmed:authorpubmed-author:CryslerCarlClld:pubmed
pubmed-article:17889527pubmed:authorpubmed-author:SpurlinoJohnJlld:pubmed
pubmed-article:17889527pubmed:authorpubmed-author:LeeLilyLlld:pubmed
pubmed-article:17889527pubmed:authorpubmed-author:PanWenxiWlld:pubmed
pubmed-article:17889527pubmed:authorpubmed-author:KreutterKevin...lld:pubmed
pubmed-article:17889527pubmed:issnTypePrintlld:pubmed
pubmed-article:17889527pubmed:day15lld:pubmed
pubmed-article:17889527pubmed:volume17lld:pubmed
pubmed-article:17889527pubmed:ownerNLMlld:pubmed
pubmed-article:17889527pubmed:authorsCompleteYlld:pubmed
pubmed-article:17889527pubmed:pagination6266-9lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:meshHeadingpubmed-meshheading:17889527...lld:pubmed
pubmed-article:17889527pubmed:year2007lld:pubmed
pubmed-article:17889527pubmed:articleTitle2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors.lld:pubmed
pubmed-article:17889527pubmed:affiliationDrug Discovery, Johnson & Johnson, Pharmaceutical Research and Development, Spring House, PA, USA.lld:pubmed
pubmed-article:17889527pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17889527lld:chembl